Telithromycin in lower respiratory tract infections
1University of Milan, Institute of Respiratory Diseases, IRCCS Ospedale Maggiore Milano, Milan, Italy. francesco.blasi@unimi.it
Future Microbiology
|July 31, 2007
Summary
Telithromycin, a potent ketolide antibiotic, effectively treats lower respiratory tract infections. Emerging data suggest it also possesses anti-inflammatory properties beneficial for airway diseases.
Area of Science:
- Pharmacology
- Infectious Diseases
- Pulmonology
Background:
- Telithromycin is a semisynthetic ketolide antibiotic derived from macrolides.
- It exhibits an expanded spectrum of activity compared to traditional macrolides.
- Telithromycin's pharmacokinetic profile supports once-daily dosing and has proven effective in lower respiratory tract infections.
Purpose of the Study:
- To review the efficacy of telithromycin in treating lower respiratory tract infections.
- To analyze the potential anti-inflammatory and immunomodulatory effects of telithromycin.
- To evaluate the drug's role in managing chronic bronchitis, community-acquired pneumonia, and asthma.
Main Methods:
- Systematic review of published data on telithromycin.
- Analysis of clinical studies concerning lower respiratory tract infections.
- Examination of pharmacokinetic and pharmacodynamic properties.
Main Results:
- Telithromycin demonstrates efficacy in treating lower respiratory tract infections.
- Evidence suggests telithromycin possesses anti-inflammatory/immunomodulatory effects.
- The drug's pharmacokinetic and pharmacodynamic properties are favorable for therapeutic use.
Conclusions:
- Telithromycin is a valuable therapeutic option for lower respiratory tract infections.
- Its anti-inflammatory properties may extend its utility to chronic airway diseases.
- Further research into telithromycin's immunomodulatory role is warranted.
Related Concept Videos
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...